Clinical Laboratory–Based Assay Methodologies May Underestimate and Increase Variability of Vancomycin Protein Binding in Hospitalized Patients

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Pharmacotherapy

• Publication date

  2014-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/phar.1323PMID 23798336
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of HPLC methods for the determination of vancomycin in human plasma, mouse serum and bronchoalveolar lavage fluid.

  2013cited by this paper
• IDSA GUIDELINES Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children

  2011cited by this paper
• Refining Vancomycin Protein Binding Estimates: Identification of Clinical Factors That Influence Protein Binding

  2011cited by this paper
• Generic Vancomycin Products Fail In Vivo despite Being Pharmaceutical Equivalents of the Innovator

  2010cited by this paper
• Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

  2009influential reference
• orrelation between free and total vancomycin serum concentrations in atients treated for Gram-positive infections

  2009cited by this paper
• Controlling for Severity of Illness in Outcome Studies Involving Infectious Diseases: Impact of Measurement at Different Time Points

  2008cited by this paper
• Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'

  2004cited by this paper
• Pharmacodynamics of a Novel Des-F(6)-Quinolone, BMS-284756, against Streptococcuspneumoniae in the Thigh Infection Model

  2003cited by this paper
• Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus.

  2000cited by this paper
• The role of albumin in critical illness.

  2000cited by this paper
• A modified HPLC method for the determination of vancomycin in plasma and tissues and comparison to FPIA (TDX).

  1998cited by this paper
• Vancomycin‐Binding Characteristics in Patients with Serious Infections

  1996cited by this paper
• Comparison of high-performance liquid chromatography with fluorescence polarization immunoassay for the analysis of vancomycin in patients with chronic renal failure.

  1995cited by this paper
• Protein binding and serum bactericidal activities of vancomycin and teicoplanin

  1995cited by this paper
• Serum protein-binding characteristics of vancomycin

  1993cited by this paper
• The influence of vancomycin concentration and the pH of plasma on vancomycin protein binding.

  1992cited by this paper
• Vancomycin Protein Binding in Patients with Infections Caused by Staphylococcus Aureus

  1991cited by this paper
• Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin

  1991cited by this paper
• Protein binding of vancomycin in a patient with immunoglobulin A myeloma

  1990cited by this paper
• The influence of serum albumin and alpha 1-acid glycoprotein on vancomycin protein binding in patients with burn injuries.

  1989cited by this paper
• Vancomycin Serum Protein Binding Determination by Ultrafiltration

  1988cited by this paper
• Rapid microbiological pH assay for the determination of cephradine in pharmaceutical formulations and biological fluids.

  1985cited by this paper
• Effect of protein binding on antibiotic activity in vivo.

  1983cited by this paper
• Successful treatment of Bacteroides bacteraemia with metronidazole, after failure with clindamycin and lincomycin.

  1977cited by this paper

• Protein binding of vancomycin in a large mixed patient population at a university hospital

  2026influential citation
• Disposable electrochemical aptasensor for rapid and selective vancomycin detection in clinical samples: Bridging affinity selection, computational modeling and clinical validation.

  2025cites this paper
• Analytical Validation of Aptamer-Based Serum Vancomycin Monitoring Relative to Automated Immunoassays

  2023cites this paper
• Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

  2022cites this paper
• Review and evaluation of vancomycin dosing guidelines for obese individuals

  2022cites this paper
• Prediction of Unbound Vancomycin Levels in Intensive Care Unit and Nonintensive Care Unit Patients: Total Bilirubin May Play an Important Role

  2021cites this paper
• Protein Binding and Population Pharmacokinetics of Dexmedetomidine after Prolonged Infusions in Adult Critically Ill Patients.

  2021cites this paper
• An adapted LC-MS/MS method for the determination of free plasma concentration of cefoperazone in children: Age-dependent protein binding.

  2020cites this paper
• Biocompatibility of a polymer-coated membrane possessing a hydrophilic blood-contacting layer: Adsorption-related assessment

  2019cites this paper
• Hypoalbuminaemia and Altered Protein Binding

  2018cites this paper
• Factors impacting unbound vancomycin concentrations in neonates and young infants

  2018cites this paper
• A bio-artificial poly([d,l]-lactide-co-glycolide) drug-eluting nanofibrous periosteum for segmental long bone open fractures with significant periosteal stripping injuries

  2016cites this paper
• Vancomycin Tissue Pharmacokinetics in Patients with Lower-Limb Infections via In Vivo Microdialysis.

  2015cites this paper
• Measuring Unbound Versus Total Vancomycin Concentrations in Serum and Plasma: Methodological Issues and Relevance

  2015cites this paper
• Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients.

  2015cites this paper
• Vancomycin serum concentrations do not adequately predict tissue exposure in diabetic patients with mild to moderate limb infections.

  2015cites this paper
• Factors Impacting Unbound Vancomycin Concentrations in Different Patient Populations

  2015influential citation
• Unbound fraction of vancomycin in intensive care unit patients

  2014cites this paper
• Pharmacokinetics of arbekacin in bronchial epithelial lining fluid of healthy volunteers.

  2014cites this paper
• Determination of the free and total concentrations of vancomycin by two-dimensional liquid chromatography and its application in elderly patients.

  2014cites this paper